Newsroom

LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced the publication of clinical results from the ovarian cancer cohort of its Phase 1b C-800-01 trial evaluating botensilimab plus balstilimab (BOT+BAL) in The Journal for ImmunoTherapy of Cancer (JITC). The peer-reviewed manuscript titled, “Botensilimab (Fc-enhanced anti–CTLA-4 antibody) plus balstilimab (anti–PD-1 antibody) in patients with treatment-refractory ovarian cancer,” i...

IRVINE, Calif.--(BUSINESS WIRE)--Alliant Insurance Services, the nation’s leading specialty broker, has hired Adam Johnson as Executive Vice President within Alliant Specialty....

LONDON--(BUSINESS WIRE)--  Xtrackers II Investment company with variable capital (Société d'investissement à capital variable) Registered office: 49, avenue J.F. Kennedy, L-1855 Luxembourg R.C.S. Luxembourg B-124.284 (the “Company”) NOTICE TO SHAREHOLDERS OF THE SUB-FUNDS LISTED ON THE LONDON STOCK EXCHANGE Luxembourg, 22 December 2025 The board of directors of the Company (the “Board of Directors”) hereby informs all shareholders of the sub-funds listed in the table below (each a “Sub-Fund”, a...

AVENTURA, Fla.--(BUSINESS WIRE)--Safe Pro Group Inc. (Nasdaq: SPAI) (“Safe Pro” or the “Company”), a developer of artificial intelligence (“AI”)-enabled defense, security, and situational awareness solutions, today announced the formation of SPAI Ventures LLC (“SPAI Ventures” or “SPV”), a wholly owned subsidiary established to evaluate and pursue selective strategic investments and collaborations with Ukrainian and other international technology developers. In conjunction with Ukrainian entrepr...

SOUTH WINDSOR, Conn.--(BUSINESS WIRE)--Brand Street Properties and Barings announced today the acquisition of The Shops at Evergreen Walk, the premier open-air lifestyle shopping destination in South Windsor, Connecticut. The acquisition follows the several-year period during which Brand Street Properties successfully managed and redeveloped the property, reinforcing the firm’s long-term commitment to Evergreen Walk and the surrounding community. Celebrating its 20th anniversary in 2024, The Sh...

SEATTLE--(BUSINESS WIRE)--U.S. home prices climbed 0.2% month over month in November on a seasonally adjusted basis, slightly smaller than October’s 0.3% monthly increase. That’s according to a new report from Redfin, the real estate brokerage powered by Rocket. Prices rose 2.6% from a year earlier, a slightly slower growth rate than October’s 2.9% year-over-year increase. Home-price growth has been slowing since the beginning of the year; November’s year-over-year increase is the smallest in r...

MADISON, Wis.--(BUSINESS WIRE)--Qolab closed 2025 with a series of strategic collaborations, product deployments, and industry leadership milestones that underscore growing momentum behind its approach to scalable superconducting quantum hardware. Together, these advances mark foundational progress toward the company’s mission to build a commercially useful quantum computer through semiconductor-aligned manufacturing and system-level integration. Throughout the year, Qolab deepened relationship...

CAMARILLO, Calif.--(BUSINESS WIRE)--Newton Golf Company (NASDAQ: NWTG) (“Newton Golf” or the “Company”), a technology-driven innovator in performance golf equipment, today announced that its shafts were the No. 1 selling shafts for both drivers and fairway woods at Club Champion in 2025, one of the largest and most respected professional club fitting retailers in the world. The recognition reflects strong demand from golfers working with professional fitters and underscores Newton’s growing pre...

BOULDER, Colo.--(BUSINESS WIRE)--Enveda, a multi-asset clinical-stage biotech company pioneering the discovery and development of a new generation of small-molecule drugs derived from life’s chemistry, today announced that the US Food and Drug Administration (FDA) has cleared the Company’s Investigational New Drug (IND) application for ENV-6946. Following this clearance, Enveda has initiated a Phase 1 clinical trial for ENV-6946, a first-in-class oral small molecule for the treatment of Inflamm...

ATLANTA--(BUSINESS WIRE)--Volato Group, Inc. (the “Company” or “Volato”) (NYSE American: SOAR), today announced preliminary financial guidance for the fourth quarter and full year ending December 31, 2025, reflecting continued execution against its strategic and balance sheet objectives. For the fourth quarter of 2025, Volato expects to report revenue between $27 million and $28 million. For the full year 2025, the Company anticipates total revenue between $78 million and $79 million, with net...